BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $2,721,658 (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 40.2%

Value ($000) $1,094,126 Shares 40,538,196 Est. Cost $17.18 Unrealized +52.5%

— MICHAELS COS INC 26.3%

Value ($000) $714,898 Shares 52,798,929 Est. Cost $17.48 Unrealized —

IQV IQVIA HLDGS INC 12.7%

Value ($000) $345,147 Shares 2,971,054 Est. Cost $101.80 Unrealized +19.0%

SGRY SURGERY PARTNERS INC 9.5%

Value ($000) $259,001 Shares 26,455,651 Est. Cost $14.30 Unrealized -6.1%

— ATENTO S A 7.1%

Value ($000) $194,568 Shares 48,520,671 Est. Cost $10.45 Unrealized —

— VERITIV CORP 2.6%

Value ($000) $69,512 Shares 2,783,840 Est. Cost $50.06 Unrealized —

— FRANKS INTL N V 1.6%

Value ($000) $44,406 Shares 8,506,930 Est. Cost $12.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1,094,126	40.2%	$17.18	+52.5%	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$714,898	26.3%	$17.48	—	COM	59408Q106
IQV	IQVIA HLDGS INC	2,971,054	$345,147	12.7%	$101.80	+19.0%	COM	46266C105
SGRY	SURGERY PARTNERS INC	26,455,651	$259,001	9.5%	$14.30	-6.1%	COM	86881A100
—	ATENTO S A	48,520,671	$194,568	7.1%	$10.45	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$69,512	2.6%	$50.06	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$44,406	1.6%	$12.31	—	COM	N33462107